Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
1700
INR+13.80
(+0.82%)Day's range
1691.3
1748.5
52 wk Range
1377.2
1960.35
Key ratios
Statements Highlights
| Period Ending | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | |
|---|---|---|---|---|---|---|
| Total Revenue | 323,251,700,000 | 331,391,800,000 | 384,264,200,000 | 432,788,700,000 | 477,584,500,000 | |
| Gross Profit | 218,539,000,000 | 232,537,600,000 | 267,187,700,000 | 326,167,100,000 | 229,463,400,000 | |
| Operating Income | 49,477,700,000 | 64,276,200,000 | 81,471,700,000 | 93,047,500,000 | 104,681,800,000 | |
| Net Income | 37,649,300,000 | 29,038,200,000 | 32,727,300,000 | 84,735,800,000 | 95,763,800,000 | |
| Total Assets | 682,524,600,000 | 676,667,300,000 | 697,998,700,000 | 807,435,900,000 | 854,628,800,000 | |
| Total Current Liabilities | 157,064,300,000 | 161,456,300,000 | 172,005,500,000 | 199,063,800,000 | 169,844,000,000 | |
| Total Equity | 491,246,900,000 | 494,798,300,000 | 510,661,100,000 | 593,154,700,000 | 671,059,700,000 | |
| Free Cash Flow | 50,127,700,000 | 50,002,400,000 | 74,895,000,000 | 28,737,500,000 | 99,331,700,000 | |
| Cash from Operations | 65,547,700,000 | 61,703,700,000 | 89,845,400,000 | 49,593,300,000 | 121,349,800,000 | |
| Cash from Investing | -25,888,400,000 | 5,362,200,000 | -57,247,400,000 | -79,436,800,000 | -6,902,000,000 | |
| Cash from Financing | -57,151,400,000 | -59,804,800,000 | -51,934,600,000 | 23,760,700,000 | -67,101,600,000 | |
| Net Change in Cash | -13,856,900,000 | 5,964,200,000 | -17,647,800,000 | 1,154,800,000 | 46,619,200,000 |